-
Science & technology
Science & technology
Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
- Overview
- Our pipeline
- Matrix-M™ adjuvant
- Recombinant, protein-based nanoparticle vaccine
- Global vaccine approval/authorization map
COVID-19 UPDATESNovavax has demonstrated its ability to quickly produce viable vaccine candidates for emerging infectious diseases such as COVID-19.
-
Who we are
Who we are
We are a biotechnology company committed to help address serious infectious disease globally through the discovery, development, and delivery of innovative vaccines to patients around the world.
Build your future with usJoin other passionately curious people who are bringing innovative vaccines to the world
-
Insights
Insights
Novavax is committed to accelerating the development of new and promising vaccines by building on years of study and experience.
Email us
Use this form to submit your request. At this time we can answer inquiries in English, Spanish, German, Italian, French, Czech, Swedish and Portuguese. For other languages, please utilize our other channels. We will respond to your request as soon as possible.
Your privacy is of the highest priority to us. Please do not include any confidential details in this form.
If you would like to submit a Product Quality Complaint, Adverse Event, or Medical Information Request, please visit the Global Medical Information site.
All fields marked with asterisk (*) are required.